TR200002770T2 - Treatment of estrogen related disorders - Google Patents

Treatment of estrogen related disorders

Info

Publication number
TR200002770T2
TR200002770T2 TR2000/02770T TR200002770T TR200002770T2 TR 200002770 T2 TR200002770 T2 TR 200002770T2 TR 2000/02770 T TR2000/02770 T TR 2000/02770T TR 200002770 T TR200002770 T TR 200002770T TR 200002770 T2 TR200002770 T2 TR 200002770T2
Authority
TR
Turkey
Prior art keywords
treatment
related disorders
isoflavones
estrogen related
biocaine
Prior art date
Application number
TR2000/02770T
Other languages
Turkish (tr)
Inventor
Edmund Kelly Graham
James Husband Alan
Original Assignee
Novogen Research Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novogen Research Pty Ltd filed Critical Novogen Research Pty Ltd
Publication of TR200002770T2 publication Critical patent/TR200002770T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Steriodal estrojenlerin anormal olarak yüksek aktivitesi ile özdeslestirilen bozukluklarin tedavi, profilaksis, iyilestirme ya da önlemesine dair bir yöntem, ki bu bir insan denege yonca ya da nohutun izoflavon içeren bir özünü kapsayan bir bilesim uygulamasini kapsar, sözü edilen öz incelikle biokanin ya da biokaninin aralarinda formononetin, daidzein ve genisteinin bulundugu gruptan bir ya da daha fazla izoflavonun yaklasik 2:1 ila yaklasik 5:1 oraninda bir oranini kapsar, bu istege bagli olarak bir ya da daha fazla farmasötik olarak kabul edilebilir tasiyici, tatlandirici, yardimci ve/veya sulandirici ile birlikte tarif edilmistir. Ayni zamanda izoflavon özlerini içeren kompozisyon ve kullanimlar da tarif edilmistir.A method for the treatment, prophylaxis, healing or prevention of disorders characterized by abnormally high activity of steriodal estrogens, which involves a composition comprising an extract containing isoflavones of a human equilibrium or chickpea, said essentially between biotin or biocaine. includes from about 2: 1 to about 5: 1 of one or more isoflavones from the group in which daidzein and genistein are present, optionally with one or more pharmaceutically acceptable carriers, sweeteners, adjuvants and / or diluents. has been described. Compositions and uses containing isoflavone extracts are also described.

TR2000/02770T 1998-03-26 1999-03-26 Treatment of estrogen related disorders TR200002770T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP2607A AUPP260798A0 (en) 1998-03-26 1998-03-26 Treatment of medical related conditions with isoflavone containing extracts of clover

Publications (1)

Publication Number Publication Date
TR200002770T2 true TR200002770T2 (en) 2000-11-21

Family

ID=3806868

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02770T TR200002770T2 (en) 1998-03-26 1999-03-26 Treatment of estrogen related disorders

Country Status (16)

Country Link
US (3) US6599536B1 (en)
EP (1) EP1063990B1 (en)
JP (1) JP2002507568A (en)
AU (1) AUPP260798A0 (en)
BR (1) BR9909105A (en)
CA (1) CA2325631A1 (en)
DE (1) DE69934877T2 (en)
DK (1) DK1063990T3 (en)
ES (1) ES2281169T3 (en)
IL (1) IL138129A (en)
NO (1) NO325456B1 (en)
NZ (1) NZ506701A (en)
PT (1) PT1063990E (en)
TR (1) TR200002770T2 (en)
WO (1) WO1999048496A1 (en)
ZA (1) ZA200005070B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2225822T3 (en) * 1992-05-19 2005-03-16 Novogen Research Pty Ltd USE OF ISOFLAVONAS PHYTO-STROGEN EXTRACTS FROM SOYBEAN OR TREBOL, ANALOGS OR METABOLITES OF THE SAME AND ITS USES.
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
JP2001523258A (en) * 1997-05-01 2001-11-20 ノボゲン インコーポレイテッド Treatment or prevention of climacteric symptoms and osteoporosis
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
AUPP260798A0 (en) * 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
AU761047B2 (en) * 1999-04-28 2003-05-29 Novogen Research Pty Ltd Cardiovascular and bone treatment using isoflavones
AUPQ008399A0 (en) * 1999-04-28 1999-05-27 Novogen Research Pty Ltd Cariovascular applications
US20090233999A1 (en) * 1999-09-06 2009-09-17 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
US20040213859A1 (en) * 1999-09-17 2004-10-28 Zelickson Brian D. Organic nutrient for hair loss treatment
AUPQ520300A0 (en) * 2000-01-21 2000-02-17 Novogen Research Pty Ltd Food product and process
EP1174144A1 (en) * 2000-07-20 2002-01-23 Linnea S.A. Dry extract rich in isoflavones and process of preparation
AUPR255401A0 (en) * 2001-01-16 2001-02-08 Novogen Research Pty Ltd Regulation of lipids and/or bone density and compositions therefor
AUPR363301A0 (en) * 2001-03-08 2001-04-05 Novogen Research Pty Ltd Dimeric isoflavones
DE10114305A1 (en) * 2001-03-23 2002-09-26 Beiersdorf Ag Reducing sebum production using cosmetic or dermatological preparations containing isoflavones, useful for e.g. eliminating comedones or treating greasy hair or dandruff
EP1358872B1 (en) * 2002-04-30 2008-03-12 Cognis IP Management GmbH Use of mixtures of active compounds comprising azelaic acid and glycyrrhetic acid in the treatment of acne
US8668914B2 (en) * 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
CN101965974A (en) * 2002-07-24 2011-02-09 儿童医院医疗中心 Compositions and products containing enantiomeric equol, and methods for their making
AU2003255232A1 (en) * 2002-08-07 2004-02-25 University Of Mississippi Antigiardial agents and use thereof
AU2005239984B2 (en) * 2002-10-29 2010-06-03 Brigham Young University Use of equol for treating skin diseases
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
AU2003286781B2 (en) 2002-10-29 2009-05-21 Brigham Young University Use of equol for treating androgen mediated diseases
US20060039971A1 (en) * 2004-08-19 2006-02-23 Lee Robert E Effervescent composition including alternative hormone replacement therapy agent
EP1842541A1 (en) 2006-03-29 2007-10-10 G.I.M.-Gesellschaft Für Innovative Medizin Gmbh Nfg Ohg Plant components and extracts and uses thereof
US20110091435A1 (en) * 2008-10-24 2011-04-21 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of hair loss
US10307451B2 (en) * 2010-02-15 2019-06-04 Sinoveda Canada Inc. Phytoestrogen product of red clover and pharmaceutical uses thereof
JP2014169286A (en) * 2013-02-07 2014-09-18 Shiga Univ Of Medical Science Medicine for suppressing metrorrhagia associated with uterine fibroid
JP6985656B2 (en) * 2017-02-28 2021-12-22 ニチモウ株式会社 Composition for improving endometriosis and its manufacturing method
JP7281156B2 (en) * 2018-05-16 2023-05-25 共栄化学工業株式会社 Skin topical agent
CN111838198B (en) * 2020-08-17 2021-07-02 南通大学 Application of chickpea extract in preventing and treating crop pathogenic bacteria
WO2022250488A1 (en) * 2021-05-28 2022-12-01 연세대학교 산학협력단 Composition for prevention or treatment of ovarian endometrioma
WO2024102744A1 (en) * 2022-11-07 2024-05-16 Arizona Board Of Regents On Behalf Of The University Of Arizona Phytoserm formulations for the promotion of cognitive function, sleep quality, and mood symptoms

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2890116A (en) * 1957-10-31 1959-06-09 Emanuel M Bickoff Estrogenic factor
DE1518002C3 (en) 1965-01-02 1975-01-23 Merck Patent Gmbh, 6100 Darmstadt Isoflavans and isoflavens and processes for their production and medicinal products containing them
DE1543749A1 (en) 1966-02-16 1969-12-11 Merck Ag E Process for the preparation of 3,4-cis-4-aryl-isoflavans
US3973608A (en) 1973-08-01 1976-08-10 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Microbial production of certain isoflavones
HU168753B (en) 1974-05-03 1976-07-28
DE2643800C2 (en) 1976-09-29 1986-10-30 Fritz Werner Industrie-Ausrüstungen GmbH, 6222 Geisenheim Process for the production of xylose by the enzymatic hydrolysis of xylans
US4257984A (en) * 1977-04-04 1981-03-24 Henkel Corporation Monotertiarymonosecondarydiprimarytetramine and monotertiarymonosecondarydinitrilodiamines
US4264509A (en) 1977-06-08 1981-04-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
SU907060A1 (en) 1979-02-07 1982-02-23 Всесоюзный Научно-Исследовательский Биотехнический Институт Process for preparing rose oil
US4366082A (en) 1979-04-11 1982-12-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4390559A (en) 1979-04-11 1983-06-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
JPS5933232A (en) * 1982-08-19 1984-02-23 Tokiwa Kanpou Seiyaku:Kk Separation of saponin and flavone from leguminous plant
JPS59199630A (en) 1983-04-26 1984-11-12 Takeda Chem Ind Ltd Remedy for hypoovarianism
JPS6048924A (en) 1983-08-24 1985-03-16 Takeda Chem Ind Ltd Remedy for osteoporosis
JPS6054379A (en) 1983-09-05 1985-03-28 Takeda Chem Ind Ltd Novel 4h-1-benzopyran-4-one derivative, its preparation and its use
JPS61246124A (en) 1985-04-24 1986-11-01 Yamanouchi Pharmaceut Co Ltd Carcinostatic agent
JPS62106017A (en) 1985-11-01 1987-05-16 Yamanouchi Pharmaceut Co Ltd Anti-tumor agent
JPS62106016A (en) 1985-11-01 1987-05-16 Yamanouchi Pharmaceut Co Ltd Immuno-suppressor
JPS62126186A (en) 1985-11-28 1987-06-08 Tsumura Juntendo Inc Production of isoflavone derivative
GB8626344D0 (en) * 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
JPS6442427A (en) 1987-08-10 1989-02-14 Tsumura & Co Sialidase inhibitor
JPH0714927B2 (en) 1988-04-06 1995-02-22 キッコーマン株式会社 Method for producing isoflavone compound
JPH0267218A (en) 1988-08-31 1990-03-07 Nagakura Seiyaku Kk Virus genome inactivator
JPH0269165A (en) 1988-09-02 1990-03-08 Mitsugi Ohashi Cancer suppressing food
JP2753719B2 (en) 1988-12-15 1998-05-20 日本油脂株式会社 Manufacturing method of liposome preparation
JPH0347049A (en) 1989-03-09 1991-02-28 Sanyu:Kk Food material from waste solution 'yu' of bean-curd and preparation of health drink
US5153230A (en) * 1989-10-06 1992-10-06 Perfective Cosmetics, Inc. Topical skin cream composition
CH679584A5 (en) 1989-11-10 1992-03-13 Nestle Sa
JPH089610B2 (en) * 1990-04-06 1996-01-31 キノイン・ジョージセル・エーシュ・ヴェジェーセティ・テルメーケク・ジャーラ・エルテー Improved process for the production of substituted isoflavone derivatives
GB2261671B (en) 1991-11-16 1996-07-03 Gb Biotech Gel production from plant matter
ES2225822T3 (en) * 1992-05-19 2005-03-16 Novogen Research Pty Ltd USE OF ISOFLAVONAS PHYTO-STROGEN EXTRACTS FROM SOYBEAN OR TREBOL, ANALOGS OR METABOLITES OF THE SAME AND ITS USES.
EP0693927A4 (en) 1993-04-16 1997-05-28 Univ Tufts Med Method for treatment of menopausal and premenstrual symptoms
US5320949A (en) 1993-10-12 1994-06-14 Protein Technologies International, Inc. Process for producing aglucone isoflavone enriched vegetable protein fiber
AU680554B2 (en) 1993-10-12 1997-07-31 Archer-Daniels-Midland Company An aglucone isoflavone enriched vegetable protein whey, whey protein, and process for producing
WO1995010530A1 (en) 1993-10-12 1995-04-20 Protein Technologies International, Inc. An aglucone isoflavone enriched vegetable protein extract and isolate and process for producing
IL112061A (en) 1994-01-13 1999-10-28 Bristol Myers Squibb Co Methods for the preparation of taxanes
US5506211A (en) 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US5424331A (en) 1994-06-10 1995-06-13 Bio-Virus Research Incorporated Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis
US5547866A (en) 1994-07-20 1996-08-20 The Regents Of The University Of California Taxane production in haploid-derived cell cultures
DE4432947C2 (en) * 1994-09-16 1998-04-09 New Standard Gmbh Agent for the treatment of the skin and its use
US5516528A (en) 1995-01-13 1996-05-14 Wake Forest University Dietary phytoestrogen in estrogen replacement therapy
US5569459A (en) 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
US5679806A (en) 1995-02-24 1997-10-21 Hauser, Inc. Process for the isolation and purification of isoflavones
JPH08283283A (en) 1995-04-14 1996-10-29 Kikkoman Corp Malonylisoflavone glucoside and method for obtaining isoflavone glucoside or isoflavone aglycon from the same substance
US5639785A (en) * 1995-06-07 1997-06-17 Global Pharma, Ltd. Methods for the treatment of baldness and gray hair using isoflavonoid derivatives
US5554519A (en) 1995-08-07 1996-09-10 Fermalogic, Inc. Process of preparing genistein
US6033714A (en) * 1996-03-13 2000-03-07 Archer Daniels Midland Company Process for production of isoflavone fractions from soy
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US5702752A (en) * 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
US5821361A (en) 1996-06-11 1998-10-13 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
AU731951B2 (en) * 1996-08-30 2001-04-05 Novogen Research Pty Ltd Therapeutic methods and compositions involving isoflavones
US5726034A (en) 1996-09-06 1998-03-10 Protein Technologies International, Inc. Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same
US5804234A (en) * 1996-09-13 1998-09-08 Suh; John D. Plant protein for nutritional products and method of making same
US5733926A (en) * 1996-12-13 1998-03-31 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
AUPO644897A0 (en) 1997-04-28 1997-05-22 Novogen Inc Preparation of isoflavones from legumes
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
AU7165798A (en) 1997-04-28 1998-11-24 Anticancer, Inc. Use of genistein and related compounds to treat certain sex hormone related conditions
JP2001523258A (en) 1997-05-01 2001-11-20 ノボゲン インコーポレイテッド Treatment or prevention of climacteric symptoms and osteoporosis
US6083526A (en) 1997-05-22 2000-07-04 Gorbach; Sherwood L. Use of isoflavonoids in the treatment or prevention of postpartum depression
US6060070A (en) 1997-06-11 2000-05-09 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of aging skin and wrinkles
US5942539A (en) 1997-10-03 1999-08-24 Wake Forest University Methods of treating or preventing endometriosis with phytoestrogens
FR2769502B1 (en) 1997-10-14 2000-04-14 Sederma Sa COMPOSITIONS FOR COSMETIC OR DERMOPHARMACEUTICAL USE CONTAINING A PLANT EXTRACT OBTAINED FROM CLOVER (TRIFOLIUM SP.)
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
US6004558A (en) 1998-02-25 1999-12-21 Novogen, Inc. Methods for treating cancer with legume plant extracts
AUPP260798A0 (en) * 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
FR2781154B1 (en) 1998-07-15 2001-09-07 Lafon Labor THERAPEUTIC COMPOSITION BASED ON ISOFLAVONOIDS FOR USE IN THE TREATMENT OF TUMORS WITH CYTOTOXIC AGENTS
AUPP868599A0 (en) * 1999-02-15 1999-03-11 Novogen Research Pty Ltd Production of isoflavone derivatives
US20040072765A1 (en) * 1999-04-28 2004-04-15 Novogen Research Pty Ltd. Cardiovascular and bone treatment using isoflavones
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AUPQ520300A0 (en) * 2000-01-21 2000-02-17 Novogen Research Pty Ltd Food product and process
AUPR255401A0 (en) * 2001-01-16 2001-02-08 Novogen Research Pty Ltd Regulation of lipids and/or bone density and compositions therefor
AUPR846401A0 (en) * 2001-10-25 2001-11-15 Novogen Research Pty Ltd 6-Hydroxy isoflavones, derivatives and medicaments involving same

Also Published As

Publication number Publication date
PT1063990E (en) 2007-04-30
NO20004688D0 (en) 2000-09-19
ZA200005070B (en) 2001-12-21
EP1063990B1 (en) 2007-01-17
US6599536B1 (en) 2003-07-29
IL138129A (en) 2005-06-19
ES2281169T3 (en) 2007-09-16
NZ506701A (en) 2003-07-25
AUPP260798A0 (en) 1998-04-23
JP2002507568A (en) 2002-03-12
US20080038387A1 (en) 2008-02-14
DE69934877T2 (en) 2007-11-08
DK1063990T3 (en) 2007-05-21
CA2325631A1 (en) 1999-09-30
IL138129A0 (en) 2001-10-31
EP1063990A1 (en) 2001-01-03
NO20004688L (en) 2000-09-19
EP1063990A4 (en) 2003-01-02
WO1999048496A1 (en) 1999-09-30
DE69934877D1 (en) 2007-03-08
NO325456B1 (en) 2008-05-05
US20030219499A1 (en) 2003-11-27
BR9909105A (en) 2000-12-05

Similar Documents

Publication Publication Date Title
TR200002770T2 (en) Treatment of estrogen related disorders
TR200003735T2 (en) Prevention and treatment of disorders related to osteoporosis and menopause syndrome
SE0002286D0 (en) Compositions and method for protecting skin from UV induced immunosuppression and skin damage
NZ511593A (en) Substituted benzopyran analogs for the treatment of inflammation
ATE263157T1 (en) NEMATICIDE TRIFLUORBUTENE
PT656786E (en) USE OF PHYSIESTROGENIC EXTRACTS OF SOYBEAN ISOFLAVONE OR CLOVER
FI972793A0 (en) Use of nebivolol as an antiatherogenic agent
PT925301E (en) HIGHLY DERIVED LIPOFILOS FROM CAMPTOTECIN
NO20075066L (en) Pharmaceutical composition containing isoflavones
ATE236894T1 (en) PYRANONE COMPOUNDS FOR THE TREATMENT OF RETROVIRAL INFECTIONS
SE1064009T5 (en) Use of iris extract and Cimicifuga racemosa extract and tectorigenin as an estrogenic organ selective drug without uterotropic action
HK1043052A1 (en) Epigallocatechin-gallate for inhibiting angiogenesis
DE59706808D1 (en) USE OF 7- (2-OXA-5,8-DIAZABICYCLO 4.3.0] NON-8-YL) -QUINOLONCARBOXYLIC ACID AND NAPHTHYRIDON-CARBOXYLIC ACID DERIVATIVES FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HELICOBORIENOXYANALENOXYANIC DIRCENOXYANALIDE
WO2002019982A3 (en) Cosmetic composition and method for reducing or preventing wrinkling
NO984330L (en) Benzopyran derivatives having leukotriene antagonistic effect
FR2818148B1 (en) COMPOSITION, ESPECIALLY COSMETIC, CONTAINING 7-HYDROXY DHEA AND / OR 7-KETO DHEA AND AT LEAST ONE ISOFLAVONOID
DE68918944D1 (en) ARTIFICIAL RECEPTOR ANALOG.
ES2177811T3 (en) USE OF NITROFLAVONOIDS FOR THE TREATMENT OF ANXIETY.
WO2002089757A3 (en) Use of isoflavones in cosmetic or dermatological preparations
PT1204659E (en) SEROTONINERGIC BENZOFURANOS
PL328123A1 (en) Derivatives of banzo[c]quinolysine and method of obtaining them
DE60134702D1 (en) Mixtures of isoflavones and flavones
AU2002328824A1 (en) Isoflavone concentrate and method for production thereof
GB0306568D0 (en) Compositions of natural products and use thereof
ATE385792T1 (en) USE OF DERIVATIVES OF C2-SUBSTITUTED INDAN-1-OL SYSTEMS FOR THE PRODUCTION OF MEDICATIONS FOR PROPHYLAXIS OR TREATMENT OF OBESITAS